Topic

Humana

A collection of 1312 issues

Humana's Coverage Criteria for Enhertu in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Enhertu Covered by Humana in New Jersey Humana requires prior authorization for Enhertu (fam-trastuzumab deruxtecan-nxki) with HER2 testing, prior therapy documentation, and ILD monitoring plan. Submit via Availity provider portal with pathology reports and clinical notes. Standard approval takes 7 days; expedited 72 hours. If denied, appeal

How to Get Somatuline Depot (Lanreotide) Covered by Humana in Ohio: Complete Appeals Guide with Forms and Timelines

Quick Answer: Getting Somatuline Depot Covered by Humana in Ohio Fastest path to approval: Have your endocrinologist or oncologist submit a prior authorization request through Humana's provider portal or by calling 800-555-2546, including medical necessity documentation for your acromegaly, GEP-NET, or carcinoid syndrome diagnosis. If denied, you have

How to Get Orkambi (lumacaftor/ivacaftor) Covered by Humana in North Carolina: Prior Authorization Guide

Answer Box: Getting Orkambi Covered by Humana in North Carolina Orkambi (lumacaftor/ivacaftor) requires prior authorization from Humana for patients with cystic fibrosis who are homozygous for the F508del mutation. Start by having your CF specialist submit a PA request through Humana's provider portal with genetic testing results,

How to Get Elelyso (Taliglucerase Alfa) Covered by Humana in New York: Forms, Appeals, and Support Resources

Quick Answer: Getting Elelyso (Taliglucerase Alfa) Covered by Humana in New York Elelyso requires prior authorization through Humana's specialty pharmacy network (CenterWell). Your doctor submits the PA request via Humana's provider portal or fax to 1-888-447-XXXX (verify with source linked below). Standard approval takes up to

How to Get Tavalisse (Fostamatinib) Covered by Humana in Texas: Complete Appeals Guide

Quick Answer: Getting Tavalisse (Fostamatinib) Covered by Humana in Texas Tavalisse requires prior authorization and often a formulary exception from Humana. Your hematologist must document chronic ITP diagnosis, platelet count <30,000/μL, and failure of step therapy (steroids, IVIG, and at least one TPO receptor agonist like eltrombopag

If Orfadin (Nitisinone) Isn't Approved by Humana in Virginia: Alternative Coverage Paths and Appeal Strategies

Answer Box: Getting Orfadin (Nitisinone) Covered by Humana in Virginia If Humana denies Orfadin (nitisinone) for hereditary tyrosinemia type 1 (HT-1), your fastest path is a formulary exception request with genetic/biochemical HT-1 confirmation and dietary management documentation. Virginia patients have strong appeal rights through the State Corporation Commission'

Getting Exondys 51 (Eteplirsen) Covered by Humana in Texas: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Exondys 51 (Eteplirsen) Covered by Humana in Texas Exondys 51 requires prior authorization through Humana as a Medicare Part B medical benefit, not pharmacy coverage. Your neurologist must submit genetic testing confirming an exon 51-amenable DMD mutation, baseline cardiac/pulmonary assessments, and prior corticosteroid documentation via the

Renewing Ozempic and Mounjaro Coverage with Humana in Washington: 2026 Documentation Guide

Answer Box: Renewing Your Ozempic/Mounjaro Coverage with Humana Most Humana Medicare plans require annual prior authorization renewal for Ozempic (semaglutide) and Mounjaro (tirzepatide). Start your renewal 60-90 days before your current approval expires. You'll need updated A1C labs, adherence documentation, and a letter of medical necessity from

How to Get Enbrel (etanercept) Covered by Humana in California: Prior Authorization, Appeals, and Medical Necessity Requirements

Answer Box: Getting Enbrel Covered by Humana in California Enbrel (etanercept) is covered by Humana Medicare Advantage plans in California as a Tier 5 specialty drug requiring prior authorization (PA) and step therapy. Your fastest path to approval: 1) Have your rheumatologist gather tuberculosis screening (PPD/IGRA + chest X-ray), hepatitis

If Rezlidhia (Olutasidenib) Isn't Approved by Humana in Ohio: Alternative IDH1 Inhibitors, Formulary Exceptions & Appeal Strategies

Answer Box: Your Next Steps if Humana Denies Rezlidhia (Olutasidenib) If Humana denies Rezlidhia (olutasidenib) for IDH1-mutated AML in Ohio, you have three main options: 1) Try formulary alternatives like ivosidenib (Tibsovo) first, 2) File a formulary exception with supporting medical necessity documentation, or 3) Appeal the denial through Ohio&